Home > Boards > US OTC > Delisted >

InSite Vision Inc. (fka INSV)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 11/3/2015 9:06:18 AM - Followers: 21 - Board type: Free - Posts Today: 0


InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs.  Our mission is to develop and facilitate market entry for novel products worldwide that preserve and improve vision.


Our lead product, AzaSite® (azithromycin ophthalmic solution) 1%, is approved by the United States Food and Drug Administration (FDA) and the Therapeutic Products Directorate (TPD) of Health Canada for the treatment of bacterial conjunctivitis. AzaSite is formulated with our proprietary DuraSite® technology, which extends the residence time of the antibiotic azithromycin on the eye for several hours, thereby reducing the need for the frequent dosing regimen related to conventional anti-infective eye drops. AzaSite was launched in the U.S. in August 2007 by Inspire Pharmaceuticals, InSite’s commercial partner for the U.S. and Canada and will be marketed by international partners in Japan, Europe, South Korea, select countries in South America, Turkey and China upon approval in those countries. InSite will also pursue partnerships with companies who share our commitment to bringing innovative ophthalmic products such as AzaSite to patients worldwide.


AzaSite Plus (ISV-502), another product candidate in the AzaSite family, is currently in late-stage development for the treatment of eyelid infection and inflammation, specifically for the indication of blepharitis.


Our strategy includes maximizing AzaSite sales in the U.S. and abroad through close collaboration with marketing partners, seeking development partners for our DuraSite-enabled early-stage product candidates, and applying our expertise in ophthalmology to identify, in-license, or acquire promising new product candidates or technologies.


Commercial partnerships: InSite Vision receives royalty payments from our two commercial products, AzaSite® (azithromycin ophthalmic solution) 1% and Besivance™ (besifloxacin ophthalmic suspension) 0.6%.  AzaSite is approved in the United States and Canada and marketed by InSite Vision’s partner, Inspire Pharmaceuticals.  InSite Vision has also formed multiple strategic licensing and distribution agreements with partners to market AzaSite in select countries in Europe, Asia and South America upon regulatory approval in those regions. Besivance was approved by the U.S. Food and Drug Administration in 2009 and is being commercialized by Bausch & Lomb and Pfizer Inc.  We work closely with our partners to support and extend product sales.


Phase Chart





Authorized Shares (AS) = 240 million 
Outstanding Shares (OS) = 94.74 million

Restricted Shares = 21.73 million

Float = 73.01 million







INSV SEC Filings



INSV Management

·         Louis Drapeau
Chief Executive Officer, Vice President and Chief Financial Officer

·         Lyle M. Bowman, Ph.D.
Vice President, Development

·         David Heniges
Vice President and General Manager, Commercial Opportunities

·         Kamran Hosseini, M.D., Ph.D.
Vice President, Clinical Affairs and Chief Medical Officer

·         Surendra Patel
Vice President, Operations and Quality


INSV Contact Information

Insite Vision Inc.

965 Atlantic Avenue

Alameda, CA 94501

United States - Map

Phone: 510-865-8800

Fax: 510-865-5700

Web Site:



Daily View


Weekly View



#346   INSV: Merged with Thea Acquisition Corp.; $0.35 per share. Renee 11/03/15 09:06:18 AM
#345   Is Sun Pharma private? If so, are Lone Wolf 09/15/15 08:44:55 PM
#344 "ALAMEDA, Calif. north40000 09/15/15 04:50:46 PM
#343   hopefully, the news is that a company ssaid Kid Fraze 09/13/15 02:06:03 PM
#342   I find it interesting that the company chose Lone Wolf 09/11/15 08:31:08 PM
#341   $INSV congrats I believe this the second attempted protagonist12 09/08/15 10:21:54 PM
#340   $INSV recent news/filings stocktrademan 09/05/15 06:54:57 PM
#339   Let the bidding wars begin! Lone Wolf 09/04/15 09:47:43 PM
#338   "InSite Vision Receives Second Unsolicited Acquisition Proposal for sunspotter 09/04/15 05:06:38 AM
#337   $INSV MrK 08/26/15 10:31:12 AM
#336   so pps should remain around here til merger dshade 06/11/15 11:51:23 AM
#335   INSV left the price out. Can be found adijas 06/08/15 02:07:04 PM
#334   Why isn't this moving STOCK PSYCHIC 06/08/15 02:05:33 PM
#333   Merger news out adijas 06/08/15 11:52:38 AM
#332   Zacks upgrades to 1 on Dec 3rd! Chicadow 12/03/14 02:29:48 AM
#331   I might nible on this. Looks sound ATCrunch 11/07/14 08:59:59 AM
#330   InSite Vision, Inc. [$INSV] due diligence stocktrademan 07/13/14 10:13:15 AM
#329   Anything new happening around here? I seen they CFlitt 07/01/14 09:43:16 AM
#328   Uncle MO is coming to visit after a mattw69 04/19/14 04:07:24 PM
#327   $INSV Chart - originalnewt 12/28/13 03:22:58 PM
#326   Zacks strong buy rating. Not too shabby. DeltaAir61 12/26/13 03:32:29 PM
#325   I've watched your signature like 10X now! hahahaha Vita Nova Stocks 12/18/13 10:54:47 AM
#324   I agree this looks nice, the company is CFlitt 12/18/13 10:15:30 AM
#323   INSV - looking good here Vita Nova Stocks 12/18/13 10:03:24 AM
#322   INSV Chart is getting real close.... Sheep 12/17/13 03:11:53 PM
#321   check out whats coming could be a sleeper Dahmer 12/02/13 03:22:51 PM
#320   Nice chart Sponsoring Thought Capital 12/01/13 04:36:41 PM
#318   InSite Vision Completes Confirmatory Phase 3 Clinical Study Dahmer 11/30/13 01:52:56 PM
#317   the top line results expected next month will Dahmer 11/29/13 11:12:05 PM
#316   InSite Vision Reports Third Quarter 2013 Financial Results Dahmer 11/29/13 03:41:29 PM
#315   can this see 1 in the future? Dahmer 11/29/13 03:32:03 PM
#314   phase 3 results by years end Dahmer 11/29/13 03:31:03 PM
#313   ALAMEDA, Calif.--(BUSINESS WIRE)--October 07, 2013-- InSite Vision Incorporated z_deville 10/07/13 04:12:29 PM
#312   its brewing Dahmer 07/03/13 05:44:53 PM
#311   ~ $INSV ~ Daily Par Sar Buy Signal Penny Roger$ 07/03/13 05:42:13 PM
#310   Not only is B&L going to buy out Gold Seeker 03/20/13 05:49:24 AM
#309   A fund who held more than 14.7 million Gold Seeker 03/20/13 05:44:10 AM
#308   Recent conference call indicates Insite is going to Gold Seeker 03/20/13 05:40:43 AM
#307   Positive Phase 3 Results for BromSite™ announced Gold Seeker 03/20/13 05:34:24 AM
#306   Will it rain today? etcetera 01/10/13 08:57:15 AM
#305   I like this one too. thanks poem. INSV T-Master 11/08/12 09:34:47 PM
#304   vizioman. Marked you. I have INSV as a PoemStone 11/08/12 05:36:40 PM
#303 vizioman 09/07/12 11:11:26 AM
#302   Clinical study news out. Caveat Emptor 09/07/12 08:44:54 AM
#301   zoom zooom ALiVE 09/06/12 12:35:08 PM
#300   Heard Insite management had a meeting with Roth Daltonfiske 06/12/12 08:25:00 PM
#299   Interview (part 1) with TIm Ruane CEO of john eastman 06/12/12 09:51:03 AM
#298   I've been looking into this one for a Daltonfiske 06/06/12 01:17:23 PM
#297   Insite Vision receives broad patent approval in Japan mlkrborn 01/09/12 11:56:31 AM
#296   think its gonna turn around here now.looks like RACKnRICKY 12/23/11 12:04:59 PM